Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Theranostics|December 18, 2018
PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinomaDongmei Mai, Peirong Ding, Liping Tan, et al.
The New England Journal of Medicine|October 22, 2025
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial CancerXinan Sheng, Gongqian Zeng, Cuijian Zhang, et al.
BMC Medicine|February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trialTongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Cancer Innovation|April 8, 2025
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021Hong Zhao, Yilei Mao, Hongguang Wang, et al.
Nature Medicine|July 16, 2025
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Jianwei Yang, Yuping Sun, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2022
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)Xinan Sheng, Dingwei Ye, Aiping Zhou, et al.
The Lancet. Oncology|September 4, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trialAiping Zhou, Pengfei Shen, Juan Li, et al.
Nature Medicine|June 1, 2026
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trialZhi Peng, Tianshu Liu, Hua Wang, et al.
Liver Cancer|August 11, 2022
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert StatementsYongkun Sun, Wen Zhang, Xinyu Bi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 17, 2021
Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter surveyHong Zhao, Aiping Zhou, Jianguo Zhou, et al.
Pageof 14